Key result
Amezinium significantly increased the reduction ratio of finger-tip blood flow to cold stimulation (85.1% vs 75.9%, p<0.05) and decreased the ED50 for noradrenaline-induced venoconstriction compared to placebo in healthy men.
Why the study?
Does amezinium metilsulfate improve the vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline in healthy men?
RCT (n=8)
Single-blind
No
Does amezinium metilsulfate improve the vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline in healthy men?
A single oral dose of amezinium enhances vasoconstrictor responses to sympathetic stimulation and exogenous noradrenaline in healthy subjects, providing mechanistic insight into its utility for orthostatic hypotension.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for amezinium in orthostatic hypotension; leaves open clinical efficacy pending patient trials.
Orthostatic hypotension can be caused by an inadequate vasoconstrictor response. The effects of amezinium on vasoconstrictor response to sympathetic stimulation and to exogenous noradrenaline were investigated and compared with those of midodrine. In 8 healthy men, the following experiments were performed after a single oral dose of 10mg of amezinium, 2mg of midodrine or a placebo. First, finger-tip blood flow (FTBF) was recorded using a laser Doppler flowmeter before and during the contralateral hand cooling and a reduction ratio of FTBF was calculated as an index of the vasoconstrictor response. Second, dose-response curves to increasing doses (1-512ng/min) of noradrenaline infused locally to the dorsal hand vein were determined using a linear variable differential transformer. The reduction ratio of FTBF was significantly increased (p<0.05) by amezimium [placebo, 75.9 +/- 9.8(mean +/- SD)%; amezinium, 85.1 +/- 7.9%; midodrine, 78.1 +/- 9.3%]. The infusion rate of noradrenaline producing a half-maximum venoconstriction was significantly decreased (p<0.05) by amezinium (placebo, 40.6 +/- 33.9 ng/min; amezinium, 21.0 +/- 21.3 ng/min; midodrine, 33.2 +/- 31.5 ng/min). These findings indicate that amezinium increases the vasoconstrictor response to sympathetic stimulation and to noradrenaline in normal subjects, and this mechanism might contribute to the improvement by amezinium of the symptoms of orthostatic hypotension.
No takes yet. Share an insight, caveat, or question.
Harada et al. (1998) conducted an RCT in Healthy volunteers (n=8). Amezinium metilsulfate vs. Placebo was evaluated on Reduction ratio of finger-tip blood flow to cold stimulation (p=<0.05). Amezinium significantly increased the reduction ratio of finger-tip blood flow to cold stimulation (85.1% vs 75.9%, p<0.05) and decreased the ED50 for noradrenaline-induced venoconstriction compared to placebo in healthy men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: